Join Hep B United on Monday, December 3rd at 3:00 pm Eastern Time for updates on hepatitis B policy and advocacy! Learn about hepatitis B and liver cancer-related legislation, recent policy changes, new resources, and opportunities to get involved in hepatitis B advocacy in 2019.
Register for the update call here.
WASHINGTON, D.C. (October 24, 2018) – Hep B United today released the following statement, commending Congress for working together to pass the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act. The legislation was signed into law by the president, following overwhelming bipartisan Congressional support. The legislation supports a range of services, programs, and funding, across multiple federal agencies, to help combat the nation’s ongoing opioid epidemic and related infectious diseases, including hepatitis B.
The SUPPORT for Patients and Communities Act brings together several pieces of legislation focused on different aspects of the opioid epidemic, from promoting evidence-based prevention strategies, to researching new, non-addictive pain management drugs, and expanding access to substance use disorder treatment.
Continue reading Hep B United Applauds Bipartisan Legislation to Combat the Opioid Crisis and Opioid Related Infectious Diseases →
Please join Hep B United on Tuesday, October 30, 2018 from 2:00 PM to 3:00 EDT for a webinar on Community-Based Services to Improve Hepatitis B Testing and Linkage to Care Among Hard-to-Reach Populations.
In the U.S., up to 2 million people are living with chronic hepatitis B infection, only 25 percent are aware of their infection, and less than 10 percent of infected individuals are able to access care and receive treatment. Among those chronically infected with hepatitis B, an estimated 70 percent are non-U.S. born and face unique barriers in accessing health care services.
Join this session to learn about three hepatitis B testing and linkage to care programs funded by the Centers for Disease Control and Prevention (CDC) in 2014 to 2017. Panelists from Chicago, Livingston, New Jersey/New York City, and Sacramento will share innovative strategies and partnerships to improve testing and linkage to care among high-risk populations, including patient navigation programs, using electronic medical records, and educating health care providers.
Register at: https://attendee.gotowebinar.com/register/7419649993381033985
Continue reading Webinar: Community-Based Services to Improve Hepatitis B Testing and Linkage to Care Among Hard-to-Reach Populations →
WASHINGTON, DC (October 18, 2018) Hep B United strongly endorses the introduction of the Liver Illness Visibility, Education and Research (LIVER) Act of 2018. Introduced by Representative Nydia Velazquez (D-NY), the bill takes bold steps to increase investments in research, prevention, and awareness activities to address hepatitis B, which kills up to 1 million people a year, and liver cancer, which continues to grow in incidence and is the 2nd deadliest cancer worldwide. As hepatitis B is the major cause of liver cancer, research efforts to cure these two diseases are linked.
The LIVER Act will authorize $100 million a year for five years for prevention and awareness grants at the Centers for Disease Control and Prevention (CDC) and authorize $45 million a year for five years for hepatitis B and liver cancer research at the National Institutes of Health (NIH). The bill includes significant provisions that will support and accelerate liver cancer and hepatitis B research, and will:
Continue reading Hep B United Endorses the Liver Illness Visibility, Education, and Research (LIVER) Act of 2018 →
WASHINGTON, D.C. (July 2018) – Hep B United, a national coalition established by the Hepatitis B Foundation (HBF) and the Association of Asian Pacific Community Health Organizations (AAPCHO) to address the silent epidemic of hepatitis B, will host its sixth annual summit in Washington, D.C., July 24 to 26. The summit brings together community leaders, advocates and people with hepatitis B to promote screening and prevention strategies and advocate for equitable access to health care to further its mission to eliminate hepatitis B in the United States.
Hepatitis B is caused by a virus and is the world’s most common, serious liver infection. It is also the deadliest vaccine-preventable disease, with nearly 1 million people dying each year from hepatitis B-related disease worldwide. In the United States, up to 2.2 million Americans are chronically infected with hepatitis B, yet most do not know it. Without early diagnosis and intervention, one in four people living with hepatitis B will die prematurely from liver failure or liver cancer.
Continue reading Hepatitis B Leaders Call for the Elimination of Hepatitis B →
The annual Hep B United Summit, organized by the Hepatitis B Foundation, convenes in Washington D.C. from Wednesday, July 25 through Thursday, July 26. National and local coalition partners, experts, stakeholders, and federal partners will meet to discuss how to increase hepatitis B testing and vaccination and improve access to care and treatment for individuals living with hepatitis B.
You can watch many of these sessions on Facebook Live. You can also follow the conversation at the Summit on Twitter with #Hepbunite!
Facebook Live is live video streaming available to all Pages and profiles on Facebook. Check out the agenda below and go to the HepBUnited Facebook Page to view the live broadcast. Some breakout sessions may be broadcast from the Hepatitis B Foundation Facebook Page. Sessions will also be available following the broadcast for those who are not able to join us live.
Continue reading Join the Conversation at the Hep B United Summit; Watch Summit Sessions On Facebook Live →